Discordant HER2/Neu Status of Breast Cancer.

Malignant Neoplasm of Breast. Clinical Trial

Official title: Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.

Status Completed

Clinical Trial Summary

The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Clinical Trial Description

HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed.

The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Breast Neoplasms
• Malignant Neoplasm of Breast.
• Neoplasms

• NCT number: NCT01935739
• Study type: Observational [Patient Registry]
• Source: National Cancer Institute, Thailand
• Status: Completed
• Phase: N/A
• Start date: June 2010
• Completion date: June 2011